Today I join >600 Physicians & Scientists & thousands of team members of @WakeCancer & @LevineCancer joined as one @theNCI Comprehensive Cancer Center - world class cancer care, research & training decreasing cancer burden in the Carolinas & beyond @AtriumHealth @AtriumHealthWFB

👏👏👏Outstanding MPN oral session at #EHA26 #EHA2026 !!!!! With our growing global 🌍 #MPNSM community of researchers! #JAK2 #CALR #MPL #KIT #hepcidin | @mpdrc @harrisoncn1 @SKordasti @KordastiL @beth_psaila @pankitvachhani @AdamMead_Oxford

👉#EHA26 #EH2026 | Important oral presentation by Prof F Passamonti 🇮🇹 to kick off MPN oral session @EHA_Hematology | ph3 #Independence results #Luspatercept for patients with Myelofibrosis | #MPNSM

Celebrating Claire Harrison’s EHA Lifetime Achievement Award - Ruben Mesa (@mpdrc) @EHA_Hematology oncodaily.com/voices/ruben-m…

Good to see you all @mpdrc @Dr_AmerZeidan @tariqkewan . #EHA2026

It's always nice to see Dr. Meza @mpdrc a great mentor and role model #EHA2026

Wrapping up our second day at #EHA2026 by catching up with Ruben Mesa (@mpdrc) to hear about the two-year findings of the SURPASS-ET study, the potential of hepcidin modulation in #PolycythemiaVera, & developments that are most likely to change the treatment landscape for patients with MPNs.🩸🎥 #MPNsm #Myelofibrosis #HemOnc @EHA_Hematology

👏👏👏Absolutely brilliant lifetime career achievement award lecture by Prof .@harrisoncn1 at #EHA26 #EHA2026 this am! from #Dameshek to #DiseaseModification | @Hemasphere_EHA 🥇 🙏 🙏 #MPNSM | @MPNVoice @GMPNAN @peter_mpn @mpdrc @jyoti_nangalia @jjkiladjian |

CONGRESS | #ASCO26 | PRESENTATION Ruben Mesa @mpdrc presented findings from an integrated analysis of the efficacy of ropeginterferon alfa-2b for the treatment of patients with ET from the phase III SURPASS-ET (N = 174; ropeg n = 91, anagrelide n = 83) and phase IIb EXCEED-ET (ropeg N = 91) trials. ELN response was 58.0% with ropeg vs 19.5% with anagrelide (p<0.0001) in SURPASS-ET and 60.2% with ropeg in EXCEED-ET. Ropeg demonstrated comparable safety across the trials, with predominantly low-grade, manageable AEs in the integrated safety analysis. Findings from the integrated analysis suggest ropeg may provide a disease-modifying treatment option with a favorable benefit-risk profile across patient subgroups. Follow our live feed for more updates: mpn-hub.com/medical-informat… #MPN #MPNsm #MedicalCongress

ASCO26 Brings People Together - Ruben Mesa @mpdrc oncodaily.com/voices/ruben-m…

Deeply enjoyed and honored being part of @ASCO Cancer Care Impact Breakfast at #ASCO26”. “When we say we are making an “impact” in cancer care, who are we making it for and how do we know?” @DrWinkfield @LevineCancer @wakeforestmed

Cancer Care Impact Breakfast @ASCO to discuss what is “impact” means at the community level. Chris Lathan from @DanaFarber facilitating the discussion. What is matrix of “impact”? #ASCO26

Cancer deaths in the U.S. have declined by 33% since 1991. @theNCI-funded research has been central to that progress — alongside advances driven by the broader scientific community. It shows what sustained investment in science can achieve. go.nih.gov/UugQoGd

Tackling Key Opportunities in Pancreatic, Colorectal, Appendiceal, Liver, and Gastric Cancers - Ruben Mesa (@mpdrc) oncodaily.com/voices/ruben-m…

#GraduationDay for @wakeforestmed #ClassOf2026! As #ViceDean for #CancerPrograms I am deeply excited to join this years graduates celebrating these newly minted #Physicians as they launch their career of #Service and #Healing #ProHumanitate @WakeForest @JFreischlag

#Thrilled, #Humbled and #Inspired to join #NCIDirector @DrTonyLetai and #NCILeadership and the Directors of all of the USA @theNCI Cancer Centers today! #ClinicalTrials #CancerPrevention #RuralCancerCare #AccessForAll #NewTherapies #CancerSurvivorship @wakeforestmed

Honored to Join the American Cancer Society Board of Directors - Ruben Mesa (@mpdrc) oncodaily.com/voices/ruben-a… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter

Deeply honored to join the @AmericanCancer #NationalBoard as a Director. Excited to contribute to the growth & impact of this global #CancerOrganization locally, across the USA, and across the world. @nes047 ⁦⁦@LevineCancer⁩ pressroom.cancer.org/new-boa…

Dr. Bose @bose_prithviraj kicks off the Hematology Think Tank #TT2026 in chicago today with an amazing panel @mpdrc and Drs. Shammo and Odenike here in chicago. Looking forward to a great full day of science and discussions.

Finishing off the trip with a delicious meal with @TheElfLab & @mpdrc - I am so fortunate to have opportunities to meet with the leaders of the MPN field! Til next time… #ESH2026